Stable
Warm
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
Signal weather
The story has moved beyond the first headline and now acts as a reliable context anchor.
Why now
This story is still moving and pulling follow-up coverage.